Join A Clinical Trial For A New UTI Vaccine
For Females Aged 18-64 Years Who Experience UTI Linked to E. coli
The study is investigating a new vaccine designed to prevent urinary tract infections (UTIs) caused by E. coli, a bacteria commonly responsible for these infections. The trial will evaluate the vaccine’s efficacy and safety by comparing the health outcomes (including rates of UTIs and side effects) over one year between participants who receive the new vaccine and those who do not receive any form of vaccination.
More information about the study can be found on the study page.
If you believe you meet the eligibility criteria for this study outlined on the study page, follow the instructions below to locate and contact the nearest clinical trial site.
This study is currently enrolling participants in the United States, Argentina, and South Africa.
Step 1: Locate Your Nearest Study Site
Use the lists and maps below to find the study site closest to you. The study sites are listed by country.
United States
KANSAS – Lexana
Site Name: Johnson County Clin-Trials
Contact Name: Tisha Mauk
Phone Number: (+1) 913-825-4400
Email: [email protected]
LOUISIANA – Covington
Site Name: Velocity Clinical Research
Contact Name: Nathan Kersker
Phone Number: (+1) 985-273-0855
Email: [email protected]
NEW JERSEY – Secaucus
Site Name: Riverside Medical Group
Contact Name: Luz Taborda
Phone Number: (+1) 551-255-3859
Email: [email protected]
NEW YORK – Rochester
Site Name: Rochester Clinical Research
Contact Name: Kerry Siel
Phone Number: (+1) 585-288-0890
Email: [email protected]
PENNSYLVANIA – Philadelphia
Site Name: DM Clinical Research
Contact Name: Huma Hosain
Phone Number:
Email: [email protected]
PUERTO RICO – San Juan
Site Name: GCM Medical Group
Contact Name: Azaria Candelario
Phone Number: (+1) 787-936-2100 ext.107
Email: [email protected]
TEXAS – Huston
Site Name: Synergy Group
Contact Name: Oriana Soto
Phone Number:
Email: [email protected]
TEXAS – Weatherford
Site Name: Helios Clinical Research
Contact Name: Teresa Molina
Phone Number: (+1) 817-925-5808
Email: [email protected]
WASHINGTON – Seattle
Site Name: Seattle Clinical Research Center
Contact Name: Breana Barnes
Phone Number: (+1) 206-522-3330
Email: [email protected]
WASHINGTON – Wenatchee
Site Name: Confluence Health
Contact Name: Claire Goveia
Phone Number: (+1) 509-436-4050 ext. 66792
Email: [email protected]
Argentina
BUENOS AIRES
Site Name: Centro Medico Maffei
Contact Name: Sebastian Nuñez
Phone Number: (+54) 91141639539
Email: [email protected]
CIUDAD AUTÓNOMA BUENOS AIRES
Site Name: Clinical Trials Division Stamboulian
Contact Name: Pablo Luchetti
Phone Number: (+54) 91165369121
Email: [email protected]
CIUDAD AUTÓNOMA BUENOS AIRES
Site Name: Mautalen Salud e Investigación
Contact Name: Maria Jose Mangini
Phone Number: (+54) 1141712170
Email: [email protected]
South Africa
BOKSBURG
Site Name: Reimed PTY LTD
Contact Name: Shandre Phillips
Phone Number: (+27) 672482255
Email: [email protected]
DURBAN
Site Name: Enhancing Care Foundation
Contact Name: Penelope Madlala
Phone Number: (+27) 0649757205
Email: [email protected]
JOHANNESBURG
Site Name: Newtown Clinical Research Centre
Contact Name: Thobeka Zuma
Phone Number: (+27) 114920336
Email: [email protected]
SOSHANGUVE
Site Name: Setshaba Research Centre
Contact Name: Enough Mbatsane
Phone Number: (+27) 725190815
Email: [email protected]
Step 2: Contact the Study Site
Once you have identified the nearest study site, reach out to them via email or phone to express your interest in participating. If you are unsure whether you meet the study eligibility criteria or have any specific questions about the trial, feel free to ask when you reach out to the study site. You can use the template below:
Subject: Interest in UTI Vaccine Clinical Trial Participation
Dear [Research Site Contact],
I am interested in participating in the clinical trial for a new UTI vaccine for females aged 18-64 who experience UTIs linked to E. coli. I would like to learn more about the next steps for enrollment.
Please let me know how I can proceed and if any further information is required.
Thank you for your time.
Best regards,
[Your Name]
[Your Contact Information]
